Intrinsic Value of S&P & Nasdaq Contact Us

BioDelivery Sciences Intl, Inc. Wrrt BDSIW NASDAQ

NASDAQ • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
82/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

BioDelivery Sciences Intl, Inc. Wrrt (BDSIW) trades at a trailing P/E of 0.1. Trailing earnings yield is 2,000.00%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (2,000.00%).
  • Trailing Earnings Yield 2,000.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 79/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
82/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
~
PAST
50/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — BDSIW

Valuation Multiples
P/E (TTM)0.1
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.82
Book Value / Share$0.00
Revenue / Share$1.61
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2,000.00%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2012 $0.05 $54.54M $1.65M 3%
2013 $-1.51 $11.36M $-57.39M -505.4%
2014 $-1.12 $38.94M $-54.22M -139.2%
2015 $-0.72 $48.23M $-37.67M -78.1%
2016 $-1.23 $15.55M $-67.14M -431.9%
2017 $0.09 $61.99M $5.29M 8.5%
2018 $-0.54 $55.64M $-33.87M -60.9%
2019 $-0.18 $107.89M $-15.31M -14.2%
2020 $0.24 $156.47M $25.71M 16.4%
2021 $0.82 $166.7M $84.86M 50.9%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message